CAN008

· CANbridge Life Sciences Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAN008, covering 2018-11-19 to 2022-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of CAN008 in Subjects With GBM [Phase 2]